Distribution of ABO blood groups in childhood acute leukemia

Samin Alavi; Haleh Ashraf; Armin Rashidi; Negin Hosseini; Mehdi Abouzari; Mehdi Naderifar

doi:10.1080/08880010600907221

Distribution of ABO blood groups in childhood acute leukemia

Samin Alavi, Haleh Ashraf, Armin Rashidi, Negin Hosseini, Mehdi Abouzari, Mehdi Naderifar

Medicine - Hematology, Oncology, Transplant

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

The distribution of ABO blood groups was determined in a multicenter study of 682 pediatric patients with acute lymphoblastic leukemia (ALL) and 224 patients with acute myeloid leukemia (AML) up to 12 years old. The overall distribution of blood groups was significantly different in both ALL and AML groups from the control group (p < .001). In the ALL group there were 56.5% (95% CI: 45.8-67.1) more patients with O blood group, 35.8% (95% CI: 27.0-44.5) fewer patients with A blood group, and 26.9% (95% CI: 12.7-39.2) fewer patients with B blood group. In the AML group, there were 28.8% (95% CI: 10.8-46.9) more patients with A blood group. The results indicate that alteration in ABO antigens might be associated with an increased risk of ALL.

Original language	English (US)
Pages (from-to)	611-617
Number of pages	7
Journal	Pediatric hematology and oncology
Volume	23
Issue number	8
DOIs	https://doi.org/10.1080/08880010600907221
State	Published - Dec 1 2006

Keywords

ABO blood groups
ALL
AML
Childhood

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1080/08880010600907221

OpenUrl availability

Full text

Cite this

@article{074945d9643a4656a24f73d29322782a,

title = "Distribution of ABO blood groups in childhood acute leukemia",

abstract = "The distribution of ABO blood groups was determined in a multicenter study of 682 pediatric patients with acute lymphoblastic leukemia (ALL) and 224 patients with acute myeloid leukemia (AML) up to 12 years old. The overall distribution of blood groups was significantly different in both ALL and AML groups from the control group (p < .001). In the ALL group there were 56.5% (95% CI: 45.8-67.1) more patients with O blood group, 35.8% (95% CI: 27.0-44.5) fewer patients with A blood group, and 26.9% (95% CI: 12.7-39.2) fewer patients with B blood group. In the AML group, there were 28.8% (95% CI: 10.8-46.9) more patients with A blood group. The results indicate that alteration in ABO antigens might be associated with an increased risk of ALL.",

keywords = "ABO blood groups, ALL, AML, Childhood",

author = "Samin Alavi and Haleh Ashraf and Armin Rashidi and Negin Hosseini and Mehdi Abouzari and Mehdi Naderifar",

year = "2006",

month = dec,

day = "1",

doi = "10.1080/08880010600907221",

language = "English (US)",

volume = "23",

pages = "611--617",

journal = "Pediatric hematology and oncology",

issn = "0888-0018",

publisher = "Informa Healthcare",

number = "8",

}

TY - JOUR

T1 - Distribution of ABO blood groups in childhood acute leukemia

AU - Alavi, Samin

AU - Ashraf, Haleh

AU - Rashidi, Armin

AU - Hosseini, Negin

AU - Abouzari, Mehdi

AU - Naderifar, Mehdi

PY - 2006/12/1

Y1 - 2006/12/1

N2 - The distribution of ABO blood groups was determined in a multicenter study of 682 pediatric patients with acute lymphoblastic leukemia (ALL) and 224 patients with acute myeloid leukemia (AML) up to 12 years old. The overall distribution of blood groups was significantly different in both ALL and AML groups from the control group (p < .001). In the ALL group there were 56.5% (95% CI: 45.8-67.1) more patients with O blood group, 35.8% (95% CI: 27.0-44.5) fewer patients with A blood group, and 26.9% (95% CI: 12.7-39.2) fewer patients with B blood group. In the AML group, there were 28.8% (95% CI: 10.8-46.9) more patients with A blood group. The results indicate that alteration in ABO antigens might be associated with an increased risk of ALL.

AB - The distribution of ABO blood groups was determined in a multicenter study of 682 pediatric patients with acute lymphoblastic leukemia (ALL) and 224 patients with acute myeloid leukemia (AML) up to 12 years old. The overall distribution of blood groups was significantly different in both ALL and AML groups from the control group (p < .001). In the ALL group there were 56.5% (95% CI: 45.8-67.1) more patients with O blood group, 35.8% (95% CI: 27.0-44.5) fewer patients with A blood group, and 26.9% (95% CI: 12.7-39.2) fewer patients with B blood group. In the AML group, there were 28.8% (95% CI: 10.8-46.9) more patients with A blood group. The results indicate that alteration in ABO antigens might be associated with an increased risk of ALL.

KW - ABO blood groups

KW - ALL

KW - AML

KW - Childhood

UR - http://www.scopus.com/inward/record.url?scp=33750438121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750438121&partnerID=8YFLogxK

U2 - 10.1080/08880010600907221

DO - 10.1080/08880010600907221

M3 - Article

C2 - 17065136

AN - SCOPUS:33750438121

SN - 0888-0018

VL - 23

SP - 611

EP - 617

JO - Pediatric hematology and oncology

JF - Pediatric hematology and oncology

IS - 8

ER -

Distribution of ABO blood groups in childhood acute leukemia

Abstract

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this